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Potential importance of glomerular citrate synthase activity in The mineralocorticoid aldosterone may contribute to
remnant nephropathy. progressive renal injury. Circulating aldosterone levels
Background. Aldosterone fosters progressive renal injury, but are elevated in rats with experimental chronic renal fail-the mechanism is unknown. Both Wistar-Furth rats, which are re-
ure [1, 2] and in humans with chronic renal failure [3].sistant to aldosterone actions, and adrenalectomized Sprague-
Experimental nephropathy in rats can be amelioratedDawley rats, which lack aldosterone, are characterized by resis-
tance to remnant nephropathy and by reduced whole kidney by adrenalectomy [4], a maneuver that eliminates circu-
citrate synthase activity. Increase in citrate synthase activity is lating aldosterone, or by pharmacological blockade of
a well-characterized, specific renal response to aldosterone. aldosterone formation by treatment with an angiotensin-Therefore, we performed experiments to test the hypothesis
converting enzyme (ACE) inhibitor and an angiotensinthat enhanced citrate synthase activity contributes to remnant
type-1 (AT1) receptor antagonist [5, 6]. In addition, wenephropathy.
Methods. Rat models included Wistar (control for Wistar- have demonstrated that Wistar-Furth rats (WF), which
Furth), Wistar-Furth (resistant to aldosterone), Sprague-Daw- are resistant to mineralocorticoid actions [1, 7–10], de-
ley (normal), adrenalectomy (lacking aldosterone), and 5/6
velop reduced renal damage after 5/6 nephrectomy [2].nephrectomy (renal injury). Glomeruli were obtained by differ-
Despite the increasing amount of evidence supporting aential sieving. Citrate synthase activity was determined spectro-
photometrically. Binding characteristics of cytosolic mineralo- role for mineralocorticoids in progressive renal injury,
corticoid receptors were determined by equilibrium competition the biochemical and physiological mechanisms of this
binding between tritiated and unlabeled aldosterone. Gene mineralocorticoid action are unknown.sequencing was performed with reverse transcription-polymer-
We hypothesize that enhanced citrate synthase (CS)ase chain reaction (RT-PCR) and fluorescent dye terminators.
activity mediates the effects of mineralocorticoids to sup-Results. In glomeruli isolated from adrenalectomized Wistar
rats with intact renal mass, aldosterone stimulated a threefold port progressive renal injury. Activity of CS, a key Krebs
increase in citrate synthase activity; this stimulation was not cycle enzyme, is augmented specifically in the kidney by
observed in glomeruli from Wistar-Furth rats. Similarly, citrate
aldosterone; and, conversely, adrenalectomy, which elim-synthase activity in glomeruli isolated from adrenally intact
inates circulating aldosterone, reduces whole kidney CSSprague-Dawley rats was 65% greater than that from adrenal-
ectomized Sprague-Dawley rats. Compared to sham surgery, activity [11–13]. A prior study from our laboratory dem-
subtotal nephrectomy resulted in 100% greater glomerular ci- onstrated reduced basal and aldosterone-stimulated CS
trate synthase activity in Sprague-Dawley rats. In Wistar-Furth activity in whole kidney from WF [10]. It is intriguing thatrats, mineralocorticoid receptor binding was not reduced, and
WF and adrenalectomized Sprague-Dawley rats, both ofmutations in the mineralocorticoid receptor DNA binding seg-
which are characterized by reduced whole kidney CSment were not found.
Conclusion. Citrate synthase activity is elevated in remnant activity when renal mass is intact [10–13], are resistant
glomeruli, and experimental models characterized by reduced to renal damage after 5/6 nephrectomy [2, 4]. The present
glomerular citrate synthase activity (Wistar-Furth rats, adre-
study was designed to test this hypothesis further, withnalectomized Sprague-Dawley rats) are protected from rem-
special attention paid to the glomerulus, a major targetnant nephropathy.
of remnant injury.
Key words: Wistar-Furth rats, mineralocorticoid receptors, aldosterone,
radioligand binding, citrate synthase, remnant nephropathy, glomeruli, METHODSprogressive renal injury.
Materials
Received for publication January 31, 2002
Isotopes were obtained from New England Nuclearand in revised form August 2, 2002
Accepted for publication August 28, 2002 (Boston, MA, USA). All other materials were obtained
from Sigma Chemicals (St. Louis, MO, USA) except as 2003 by the International Society of Nephrology
156
Ullian et al: Citrate synthase in Wistar-Furth rats 157
specified in this section. Sprague-Dawley rats, W, and ther by passage through a 90-m sieve. The tissue was
WF (150 to 200 g) were obtained from Harlan Sprague- then passed through a stack of sieves (180-m, 150-m,
Dawley (Indianapolis, IN, USA). RU28362 was kindly 75-m), with collection of glomeruli on the smallest.
provided by Dr. D. Philibert, Roussel Uclaf (Romain- Glomeruli were washed once and then suspended in
ville, France). 2 mL of PBS. Purity of the glomerular preparation was
confirmed by microscopy. Total number of glomeruliAnimal surgery
in the 2 mL specimen was determined by counting all
The experiments described in this manuscript were glomeruli in a thoroughly suspended 10 L sample with
conducted in accordance with National Institutes of Health a hemocytometer and then multiplying by 200.
Guide for the Care and Use of Laboratory Animals and
with approval of the Medical University of South Caro- Corticosteroid radioligand binding
lina Animal Care and Use Committee. Rats drank tap
Cytosol as source of corticosteroid receptors was pre-water ad libitum except as indicated, were fed standard
pared from cultured vascular smooth muscle cells, kid-rat chow (Teklad, Madison, WI, USA), and were housed
ney, or colon for ligand binding, as adapted from a previ-in a dedicated room at a constant temperature of 25C
ous study [14]. Cytosol sufficient for one binding studywith a 12 hour light-dark cycle. For renal ablation, rats
was obtained from eight serum-starved, confluent 100 mm2under pentobarbital anesthesia (50 mg/kg IP) were sub-
petri dishes of cultured cells or the minced cortex fromjected to subtotal (5/6) renal ablation by right nephrec-
one kidney or the epithelium scraped from the inside oftomy and infarction of 2/3 of the left kidney by sequential
one colon. Organs or pelleted cells were resuspended inligation of branches of the renal artery. Sham renal abla-
tion consisted of an abdominal incision only. After adre- 5 mL of lysis buffer [50 mmol/L potassium phosphate,
nalectomy, accomplished via bilateral flank incisions, rats 10 mmol/L dithiothreitol (DTT), 10 mmol/L sodium mo-
were maintained on normal chow and 1% saline to pre- lybdate, and 1 mmol/L polymethylsulfourea, pH 7.0],
vent extracellular fluid volume depletion. homogenized with a Polytron, lysed using freeze-thaw
cycles, and then further homogenized using a hand-heldConscious blood pressure determinations
tissue grinder. All steps were performed strictly at 0C.
Conscious systolic blood pressures were measured The homogenate was then centrifuged at 105,000  g
in awake, warmed rats with a Natsume KN-2120-1 tail for 30 minutes. Supernatant was isolated and used imme-
manometer-tachometer. Of ten blood pressure measure- diately in binding studies.
ments obtained from each rat, the first five were dis-
Tritiated and unlabeled corticosteroids were driedcarded and the remaining data were averaged.
under nitrogen. After 300 L of cytosolic preparation
was added, final concentration of [3H]aldosterone wasCultured vascular smooth muscle cell isolation,
50 nmol/L, and final concentration of unlabeled cortico-maintenance, and characterization
steroid ranged in 10 increments from 0 to 100 mol/L.Aortas from W and WF were cleaned of endothelium,
Binding ensued on a rocker for one hour at 25C. Afterfat, and adventitia for explantation. Smooth muscle strips
the incubation period, bound steroid was separated fromwere incubated in collagenase for two hours, cut into
free steroid: 400 mL of a hydroxy apatite slurry (10%pieces, and allowed to adhere to a culture flask. Then,
a covering layer of growth medium [10% (vol/vol) new- in lysis buffer) were added to each tube at 0C for ten
born calf serum, 1% (vol/vol) nonessential amino acids, minutes, and the slurry was washed with ice-cold lysis
100 U/mL penicillin, 100 g/mL streptomycin in minimal buffer three times. The final pellet (containing bound
essential medium] was added. Cells were incubated in steroid) was suspended in scintillation fluid and counted.
humidified 5% CO2/95% air atmosphere until confluent. Binding was expressed as fmol bound steroid/mg cyto-
Medium was changed every five days. Cells were pas- solic protein. Non-specific binding was 10 to 20%.
saged every seven to ten days by harvesting with trypsin- In preliminary studies in tissues from Sprague-Dawley
ethylenediaminetetraacetic acid (EDTA) and seeded at rats (N  8 to 10), binding of [3H]aldosterone to cytosol
a ratio of 1:4. Studies were performed on cells in passages
from homogenates of whole kidney or cultured vascular
three to ten. Cells exhibited characteristic stellate mor-
smooth muscle cells was completely inhibited by the spe-phology and stained positively for smooth muscle
cific glucocorticoid RU28362, suggesting that the vast ma--actin. Endothelial cell contamination was minimal
jority of corticosteroid receptors in these preparations(3%), as assessed with antibodies to the endothelial
were Type II (glucocorticoid) receptors rather than Type Icell marker factor VIII-related antigen.
(mineralocorticoid) receptors. In contrast, RU28362 in-
Isolation of glomeruli hibited only a portion of binding of [3H]aldosterone to
cytosol from homogenates of colon, thus allowing the as-After decapsulation, renal cortices were isolated, minced
in phosphate-buffered saline (PBS), and dispersed fur- sessment of Type I (mineralocorticoid) receptor binding.
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forward (24 mer)—5-Renal CS activity
CCACACGGTGACCTGTCATCTAGG-3The formation of citrate from acetyl CoA and oxalo-
reverse (26 mer)—5-acetate is catalyzed by citrate synthase, with CoA-SH
CTTGGTCGGAGCGATGTATGTGGTCC-3as a by-product. CS activity was quantitated as described
previously [10] by measuring rate of generation of
cDNA synthesis was carried out at 48C for 45 minutesCoA-SH as it reacted with 5,5-dithio-bis(2-nitrobenzoic
followed by incubation at 94C for two minutes, and thenacid) (Ellman’s reagent) to form a yellow mercaptide
40 cycles of three-step PCR were performed as follows:ion, which was quantitated spectrophotometrically. A
94C for 30 seconds, 55C for one minute, and 68C fortotal of 975 L of substrate (0.25 mmol/L Ellman’s re-
two minutes. The amplified 449 base-pair fragment wasagent, 0.2 mmol/L sodium oxaloacetate, 0.1 mmol/L ace-
visualized by electrophoresis on a 1% agarose gel andtyl CoA, 100 mmol/L Tris-Cl buffer, pH 8.0) were added
then purified on a QIAquick Spin column (Qiagen, Inc.,to 25 L (50 g protein) of enzyme source (described
Valencia, CA, USA). Purified polymerase chain reactionlater in this section) in a 1 cm-thick cuvette at room
fragments were sequenced with dRhodamine fluorescenttemperature. Absorbance at 412 nm was measured every
dye terminators (Perkin Elmer-ABI, Foster City, CA,15 seconds for five minutes. Absorbance was converted
USA) using an ABI 377A DNA sequencer, by the Medi-to concentration of mercaptide ion using the Lambert-
cal University of South Carolina Biotechnology Re-Beer law (A  ecw), where A is absorbance, e is molar
source Laboratory.absorbancy index (13,600 for the mercaptide ion), c is
concentration of mercaptide ion in M, and w is thickness Protein determination
of the reaction container in cm. The plot of product (mer-
Sample protein content was determined by the Lowrycaptide ion) concentration versus time was linear for the
method [16]. Absorbances were read at 660 nm.initial three to five minutes and allowed calculation of
Vmax in mol/mg protein/min. In control studies (enzyme Statistical considerations
source with no substrate, substrate with no enzyme
Binding data were analyzed by using the Sigma Plot soft-
source), increases in absorbance were not observed.
ware program (Jandel Scientific, Corte Madera, CA, USA).
For preparation of CS from whole kidney, one kidney Group means were compared by two-tailed, unpaired t test,
was decapsulated and homogenized in buffer (0.25 mol/L factorial one-way analysis of variance (ANOVA), or the
sucrose, 5 mmol/L EDTA, 10 mmol/L potassium phos- Wilcoxon sign rank test, where appropriate. Significant
phate, pH 7.4). For preparation of CS from glomeruli, difference was assigned at the 0.05 level.
all glomeruli from one or two kidneys were isolated by
sieving and homogenized in the same buffer. Homoge-
RESULTSnate was centrifuged at 600 rpm for 10 minutes, and the
supernatant was isolated and centrifuged at 13,000 rpm Effects of aldosterone on CS activity in glomeruli
for 15 minutes at 4C. The pellet was washed once with Wistar-Furth and adrenalectomized Sprague-Dawley
homogenization buffer and then resuspended in 1 mL of rats are protected from renal injury after subtotal renal
homogenization buffer. Ten microliters of Triton X-100 mass reduction [2, 4]. Decreased CS activity has been
were added for ten minutes at 4C to release mitochon- observed in whole kidney preparations from WF [10] and
drial contents. Membranes were removed by centrifuga- from adrenalectomized Sprague-Dawley rats [11–13], but
tion at 13,000 rpm for 15 minutes. The supernatant was it is not known if the CS activity is specifically reduced
isolated and the protein content adjusted to 1 mg/mL. in glomeruli, the main renal site in which damage occurs
when renal mass is reduced. Initial studies were per-
Mineralocorticoid receptor gene sequencing formed in Sprague-Dawley rats, our normal laboratory
RNA was isolated from whole kidney by the guanidi- strain, to determine if increases in CS activity in response
nium isothiocyanate method. A 449 base-pair DNA frag- to aldosterone occur in glomeruli. Studies were per-
ment of the mineralocorticoid receptor gene, corre- formed at least seven days after bilateral adrenalectomy
sponding to the region coding for the DNA binding to eliminate the influence of endogenous mineralocorti-
segment of the receptor (amino acids 604–659), was am- coids. Glomeruli were isolated by differential sieving and
plified from 1 g of total kidney RNA by reverse tran- treated ex vivo with aldosterone. Aldosterone elicited
scription-polymerase chain reaction (RT-PCR). This was time-dependent and concentration-dependent increases
performed with the Access RT-PCR System (Promega, in glomerular CS activity, with a maximum increase after
Madison, WI, USA), which uses AMV reverse tran- a two-hour exposure to 1 nmol/L aldosterone (Fig. 1).
scriptase and Tf1 DNA polymerase. The following prim- Variability in basal values between animals may have
ers were used to amplify bases 1687–2136 of the coding obscured increases in CS activity in response to greater
aldosterone concentrations.region of the rat mineralocorticoid receptor gene [15]:
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Fig. 2. Glomerular citrate synthase (CS) activity responses in adrenal-
ectomized Wistar (W), Wistar-Furth (WF), and Sprague-Dawley rats. W
and WF were adrenalectomized and observed for 1 week, and Sprague-
Dawley rats were adrenalectomized or sham-operated and observed
for 1 week. Glomeruli were isolated and pooled from both kidneys of
each rat, divided into 8 aliquots of 200 L each, and exposed to 0 or
1 nmol/L aldosterone for 2 hours. Glomerular CS activity was measuredFig. 1. Aldosterone stimulates citrate synthase (CS) activity in glomer-
in duplicate aliquots for each experimental maneuver and expressed asuli ex vivo from Sprague-Dawley rats. Sprague-Dawley rats were adre-
mol citrate/mg protein/min. Five rats from each strain were used. Sincenalectomized and observed for one week. Glomeruli were then isolated
the W-WF study and the Sprague-Dawley study were not performed onand pooled from both kidneys of each rat, divided into 10 aliquots of
the same day with the same batch of substrate, their data cannot be200 L each, and exposed to 0 or 10 nmol/L aldosterone for 1, 2, or 3
compared. A break in the x-axis denotes this fact. Abbreviations are:hours (A) or 0, 0.1, 1, 10, or 100 nmol/L aldosterone for two hours (B).
Aldo, aldosterone; ADX-adrenalectomized.Glomerular CS activity was measured and expressed as mol citrate/mg
protein/min. Six rats were used in Study A and 6 in Study B.
fraction did not contain glomeruli. Aldosterone did not
increase CS activity (mol citrate/mg protein/min) inTo assess the specificity of aldosterone in increasing
this tubular preparation: 0.099  0.024 (control) versusglomerular CS activity, we exposed isolated glomeruli
0.104  0.022 (aldosterone; NS, N  5). Therefore, noto angiotensin II, a potent hormone of the renin-angio-
additional studies were performed with the renal tubulartensin-aldosterone axis that is biochemical distinct from
fraction. The fact that renal tubular responses of WF toaldosterone. Glomeruli were exposed to 100 nmol/L an-
aldosterone in vivo appeared to be normal [17] also di-giotensin II for 30 minutes or two hours ex vivo, and
rected our studies away from the tubulointerstitium andthen CS activity was measured. Angiotensin II did not
toward the glomerulus.increase glomerular CS activity after either of these time
Once we identified the conditions under which aldo-periods (mol citrate/mg protein/min): 0.250 0.046 (30
sterone optimally increases CS activity in glomeruli iso-min vehicle) versus 0.239 0.060 (30 min angiotensin II),
lated from normal (Sprague-Dawley) rats, the increasesand 0.214  0.055 (2 h vehicle) versus 0.216  0.070 (2 h
in glomerular CS activity in response to aldosterone inangiotensin II; both NS, N  4).
W were compared to those in WF. A two-hour exposureBecause renal mass reduction results in fibrosis of the
of isolated glomeruli to 1 nmol/L aldosterone elicited arenal tubules and interstitium as well as glomerular scle-
threefold increase in citrate synthase activity in W butrosis, we assessed CS activity in response to aldosterone
none in WF (Fig. 2). Interestingly, basal citrate synthasein a tubular preparation. Tubular fragments that tra-
activity (mol/mg glomerular protein/min) was signifi-versed all the sieves were exposed to 1 nmol/L aldoste-
rone for two hours. Microscopy confirmed that this sieved cantly lower in glomeruli from WF (0.058  0.003) com-
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pared to W (0.0757 0.005; P 0.05). Figure 2 also dem-
onstrates that adrenalectomy reduces glomerular CS ac-
tivity in Sprague-Dawley rats by 40%. Taken together,
these studies demonstrate that glomerular CS activity,
like whole kidney CS activity, is significantly reduced in
WF and adrenalectomized Sprague-Dawley rats.
Mechanism of reduced citrate synthase activity in WF
Abnormal renal citrate synthase activity could result
from the inability of abnormal mineralocorticoid recep-
tors to transduce the aldosterone signal or from an abnor-
mal post-receptor signal. For our initial investigation into
mineralocorticoid receptor function in WF, the ligand
binding moiety of the mineralocorticoid receptor was
assessed by radioligand binding studies. Cytosol was iso-
lated from serum-deprived, cultured vascular smooth
muscle cells and from kidney and colon from adrenalec-
tomized W and WF for binding with [3H]aldosterone.
Serum deprivation of cultured cells and adrenalectomy
in intact animals were performed to avoid prior occu-
pancy of mineralocorticoid receptors. Our preliminary
studies demonstrated that binding to mineralocorticoid
receptors cannot be appreciated in vascular smooth mus-
cle cells and whole kidney (that is, glucocorticoid recep-
tors predominate), whereas binding to mineralocorticoid
receptors can be appreciated in colonic preparations
(Methods section). In all three tissue types, [3H]aldoster-
one binding to cytosolic proteins was competitively in-
hibited by increasing concentrations of unlabeled aldo-
sterone (Fig. 3). Qualitatively, binding was not reduced
in WF compared to W in any preparation. Neither miner-
alocorticoid receptor density [2.3  0.2 (W) vs. 4.8  0.5
(WF) fmol/mg cytosolic protein, P  0.05] nor binding
affinity [0.25  0.03 (W) vs. 0.28  0.03 (WF) mol/L]
was reduced in WF compared to W. In fact, receptor
density was significantly greater in WF compared to W.
To investigate a different portion of the mineralocorti-
coid receptor in WF, the gene sequences of the DNA
binding domain of mineralocorticoid receptors from W Fig. 3. Binding of [3H]aldosterone to cytosol from kidney (A), colon (B),
and vascular smooth muscle cells (C ) in W () and WF (). Cytosoland WF were determined. For this analysis, total RNA
was prepared from cultured vascular smooth muscle cells that had beenextracted from kidneys from W and WF was used as tem- serum-deprived for 24 hours and from kidney and colon from rats that
plates for reverse transcription and polymerase chain had been adrenalectomized 1 week before. Competitive aldosterone bind-
ing to cytosolic constituents was performed as described in the Methodsreaction amplification, using primers flanking the DNA
section. Studies in colon were performed in the presence of 1 mmol/Lbinding domain of the rat mineralocorticoid receptor, of the specific glucocorticoid RU28362 to allow assessment of mineralo-
that is, amino acids 604 to 659 (Methods section). The corticoid receptors. Studies were performed 8 to 10 times for each tissue.
resulting 449 base-pair polymerase chain reaction frag-
ments were purified (Fig. 4) and sequenced by automated
fluorescent DNA sequencing techniques. The nucleotide
studies reduced enthusiasm for further investigations ofsequences of the amplified cDNA fragments from W
the mineralocorticoid receptor and suggest that a post-and WF were found to be identical to each other and to
receptor aldosterone signal is abnormal.the published sequence from the normal rat [15].
Taken together, these studies demonstrate that the
Glomerular CS activity in remnant kidneystructure and function of the ligand-binding and DNA-
In addressing the hypothesis that increased glomerularbinding segments of the mineralocorticoid receptor ap-
pear not to be grossly abnormal in WF. These negative CS activity contributes to progressive renal injury, we ob-
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Fig. 4. Reverse transcription-polymerase chain reaction (RT-PCR)
product of cDNA from the DNA-binding domain of the mineralocorti-
coid receptor in W and WF. RNA was isolated from whole kidney of
W and WF. A 449-base-pair region spanning the DNA-binding domain
of the mineralocorticoid receptor was amplified with RT-PCR, purified,
and sequenced. Lane 1, standards starting at 200 base-pairs and increas-
ing by 100; lanes 2–5, W; lanes 6–9, WF; lane 10, RNA control and
primers. Differences in densities within each strain resulted from dif-
fering MgSO4 concentrations.
Table 1. Somatic and renal parameters in sham-operated and 5/6-
nephrectomized Sprague-Dawley rats
Body weight Kidney weight
Glomeruli Albuminuria
g per kidney mg/day
Sham 2354 1.0570.027 18,640900 143
Remnant 16410a 1.0140.089 4,020538a 26137a
Abbreviations are: sham, sham-operated; remnant, 5/6-nephrectomized.
a P  0.01 compared to sham
Fig. 5. CS activity in sham and remnant kidney. Sprague-Dawley ratsserved reduced whole kidney and glomerular CS activity
were subjected to sham surgery or 5/6 nephrectomy and observed forin two experimental models (WF and adrenalectomized
4 weeks. CS source was prepared from the left kidney from each of 9
Sprague-Dawley) characterized by protection against re- sham-operated animals and the remnant kidney from each of 9 5/6-
nephrectomized animals (A); and from glomeruli isolated from the leftnal damage when renal mass is reduced. Our next studies
kidney from each of 10 sham-operated animals and from glomeruliwere designed to investigate the corollary situation, that
isolated from the remnant kidney from each of 10 5/6-nephrectomized
is, that a reduction of renal mass would result in increased animals (B). CS activity was measured and expressed asmol citrate/mg
protein/min and mol citrate/105 glomeruli/min.citrate synthase activity in the remaining kidney and glo-
meruli. These studies were performed in our normal lab-
oratory rat strain, Sprague-Dawley. At four weeks after
sham surgery or 5/6 nephrectomy, urine was collected greater in whole remnant kidney compared to whole
in metabolic cages for 24 hours, body weights were mea- normal kidney. The study was then repeated for mea-
sured, conscious blood pressure was determined, and ani- surement of glomerular CS activity. We found that CS
mals were sacrificed. Table 1 demonstrates that renal activity was almost 100% greater in glomeruli from 5/6-
mass reduction was accomplished: 5/6 nephrectomy re- nephrectomized animals compared to CS activity in glo-
duced number of glomeruli per kidney by 75%, renal meruli from sham-operated animals (Fig. 5B).
hypertrophy had occurred (remnant kidneys had grown
to equal the weights of normal kidneys), and renal mass
DISCUSSIONreduction effected renal injury (marked increase in albu-
minuria). Systolic blood pressure was 35 to 40 mm Hg Prior studies have demonstrated that adrenalectomy
greater in remnant animals than normal animals. Figure in standard laboratory rat strains, such as Sprague-Daw-
ley, resulted in reduced levels of circulating aldosterone,5A demonstrates that CS activity was more than 50%
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reduced whole kidney CS activity [11–13], and reduced of how the data were expressed (mol citrate per mg
glomerular protein per minute or mol citrate per glo-renal damage after renal mass reduction [4]. Similarly,
WF, which are not deficient in circulating aldosterone merular number per minute). Taken together, the corre-
lation of reduced CS activity in glomeruli from WF priorbut appear to be resistant to the actions of aldosterone at
the tissue level [1, 10], are also characterized by reduced to renal mass reduction with reduced renal damage after
renal mass reduction in WF and the increase in CS inwhole kidney CS activity [10] and reduced renal damage
after renal mass reduction [2]. These data are consistent remnant glomeruli in Sprague-Dawley rats support our
hypothesis. It is possible that the increase in glomerularwith the possibility that decreased renal CS activity pro-
tects against progressive renal injury. The corollary possi- CS activity in remnant glomeruli is a result of the glomer-
ular damage rather than a contributor to the glomerularbility is that increased CS activity contributes to progres-
sive renal injury. Our present study was designed to gather damage. However, the opposite cannot be so, that is, that
reduced CS activity is a result of the reduced renal dam-further preliminary data in support of this hypothesis.
In whole kidney of normal rats, aldosterone activates age in WF or adrenalectomized Sprague-Dawley ani-
mals, since subnormal renal CS activity exists prior toCS, and removal of aldosterone, that is, adrenalectomy,
reduces CS activity. However, we wondered if aldoste- renal mass reduction in these two rat models (Fig. 2).
Although correlation of glomerular CS activity withrone activates CS in glomeruli as in whole kidney prepa-
rations. The answer to this question becomes relevant to glomerular damage over a wide range of glomerular ci-
trate synthase activities is consistent with our hypothesis,studies on the role of glomerular CS activity in remnant
nephropathy, because the glomerulus is a major site of more studies are needed to prove the hypothesis. For
example, we will repeat the experiment in Figure 5, per-injury after 5/6 nephrectomy. By studying isolated glo-
meruli, we eliminated the influence of circulating and formed here with Sprague-Dawley rats, in W and WF.
We predict that CS activity in glomeruli isolated fromhemodynamic factors. In preliminary studies in Sprague-
Dawley rats, we found that aldosterone can activate glo- remnant kidney will be greater than CS activity in glo-
meruli isolated from sham-operated kidney in W, as inmerular CS ex vivo in a time- and concentration-depen-
dent fashion (Fig. 1). Aldosterone also activates CS in Sprague-Dawley rats. In WF, however, we predict that
glomerular CS activity will not increase with renal massglomeruli isolated from W (Fig. 2), just as we had found
in other normal (Sprague-Dawley) rats (Fig. 1). In con- reduction, because WF are characterized by subnormal
expression of CS. The development of remnant nephrop-trast, aldosterone was unable to elicit an ex vivo increase
in CS activity in glomeruli isolated from WF (Fig. 2). In athy may depend upon the ability of CS activity to increase
in the remnant glomeruli after renal mass reduction.addition, basal glomerular CS activity was lower in WF
compared to W and in adrenalectomized Sprague-Daw- Involvement of increased Kreb cycle enzyme activity
in the pathogenesis of remnant nephropathy has notley rats compared in adrenally-intact Sprague-Dawley rats
(Fig. 2). These results and results from our prior study been previously proposed. The classical theory of aldo-
sterone’s mineralocorticoid actions in the distal renaldemonstrate that WF and adrenalectomized Sprague-
Dawley rats, both of which are resistant to renal damage tubule consists of effects on luminal permeability (in-
creased number or activity of epithelial sodium chan-when renal mass is subtotally ablated [2, 4], are character-
ized by reduced CS activity not only in the intact kidney nels), sodium pumps (increased number or activity of
Na,K-ATPase, and metabolism (activated mitochondrialbut specifically in glomeruli from intact kidney, a major
target site of renal damage when renal mass is subtotally enzyme activity to generate ATP) [11]. It has been sug-
gested that heightened activity of the Kreb cycle mayablated. These results are essential for support of the
hypothesis that activation of CS contributes to glomeru- provide fuel for the sodium pumps to accomplish anti-
natriuresis. In remnant glomeruli, increases in CS activitylar damage after 5/6 nephrectomy. This is the first report
of increases in CS activity upon exposure to mineralocor- and ATP may be necessary to fulfill the energy demands
for aldosterone-induced glomerular alterations that leadticoids in glomeruli. Prior studies have documented renal
cortical collecting duct, whole kidney, and myocardium to hypertrophy, hyperfiltration, and glomerulosclerosis.
Although not designed for this purpose, the presentas tissues that respond to aldosterone with increases in
CS activity [13]. The existence of glomerular mineralo- studies furnish information on mechanisms of resistance
to the actions of mineralocorticoids in WF. Increased cir-corticoid receptors has been documented [18].
Having determined that basal and aldosterone-stimu- culating aldosterone levels [1, 2] and failure to develop
hypertension when mineralocorticoid and salt are admin-lated glomerular CS activities are reduced in WF, a strain
of rat that develops a significantly lesser amount of renal istered [1, 7–10] are consistent with resistance to aldoste-
rone action at the end organ. The inability of aldosteronedamage after renal mass reduction [2], we examined the
corollary hypothesis: renal mass reduction in normal rats to effect increases in glomerular CS activity in WF (Fig. 2)
stimulated us to investigate mineralocorticoid receptorresults in increased CS activity in the remaining glomer-
uli. Indeed, we found this to be true (Fig. 5), regardless function. The mineralocorticoid receptor, the initial aspect
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of the aldosterone signal transduction pathway, has been WF [17] and because aldosterone stimulates hypoka-
shown to be abnormal in humans with aldosterone resis- lemia equally well in W and WF [1, 10]. Nothing is known
tance, that is, pseudohypoaldosteronism [19, 20]. We ex- about the early response genes (K-Ras2 and sgk) in WF.
amined mineralocorticoid receptor function by molecu- We have demonstrated that basal CS activity and re-
lar and biochemical techniques. Our findings—that ligand sponses of CS activity to mineralocorticoids are distinctly
binding of aldosterone to mineralocorticoid receptors is abnormal in kidney from WF. Abnormal expression of
not reduced in WF (Fig. 3) and that the gene sequence CS may be the abnormality in the mineralocorticoid sig-
of the DNA binding domain of the mineralocorticoid nal transduction pathway that mediates resistance to
receptor is not abnormal in WF—demonstrate normal mineralocorticoids in WF.
structure and function of two major moieties of the min-
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